Canaccord raises 10X Genomics stock price target on AI, biopharma growth

product launch active 96% AI & Tech

Canaccord has raised the stock price target for 10X Genomics, citing growth prospects in AI and biopharma sectors. This adjustment reflects optimism around advancements and market potential in biotechnology and artificial intelligence industries.

🌐 Location: CY — Sources: 14 — First seen: — Last seen:
Canaccord 10X Genomics stock price target AI growth biopharma

Linked Entities

Canaccord

organization involved

10x Genomics

organization involved 🇺🇸

Nanox AI

organization involved

Intel

organization involved 🇺🇸

Meta Platforms

organization involved 🇺🇸

Rackspace

organization involved

Syntetika

organization involved

Freedom Broker

organization involved

A10 Networks

organization involved

Micron

organization involved

AvePoint

organization involved

Technology Leadership Forum 2026

organization involved

Cyprus

location involved 🇬🇧

Vara

organization involved

Nvidia

organization involved 🇺🇸

Aecom Technology

organization involved

Upwork

organization involved

Andreas Bechtolsheim

person involved

Arista Networks

organization involved

George Kurtz

person involved

CrowdStrike

organization involved

Contributing Articles